Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nevis Brands Inc NEVIF


Primary Symbol: C.NEVI

Consumer Defensive Household & Personal Products
Nevis Brands Inc., formerly Pascal Biosciences Inc., provides cannabis brands throughout the United States. The Company provides products in Washington, Oregon, California, Ohio, Arizona and Colorado through partners and licensees. Its products include Major, which is a cannabis beverage. Major is a high-dose tetrahydrocannabinol (THC) beverage that delivers a consistent cannabis experience... see more

Bullboard (CSE:NEVI)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by Pascalbioson Apr 30, 2021 3:41pm

RE:Yesssss! $$$$🚀🚀 PAS Look at this one now!!! 0.35¢ 🚀🚀 $$$

Anonymous is buying a lot of stocks and will sell at 0.35 ¢ minimum or 0.40 ¢ on the next big news according to technical analysts. Recent Trades - All 7 today  ...more  
113
Discussion
Post by BayouEmpireon Apr 30, 2021 3:27pm

Up, up

Everybody by before the lift off!!!! only 160k before .0175$!!!! Only 340500 shares before .30 $ and only 478k shares before .40$ good newsssss
77
Post by Pascalbioson Apr 30, 2021 9:09am

> SEDAR financial statements < $$$$$$$$$$$$$$$$$$$$$$$$$$$$$

https://www.stockwatch.com/News/Sedardoc/4818779.pdf https://www.stockwatch.com/News/Sedardoc/4818780.pdf
98
Post by BayouEmpireon Apr 29, 2021 5:24pm

Load

Its time To load your wallet before the lift To 0.35$!!! Up,Up!
78
Comment by Kani0ikan123456on Apr 27, 2021 11:24am

RE:🚀🚀 PAS Look at this one now!!! 0.085¢ 🚀🚀

Wow! Trust you are well rewarded! May your balance go to the moon and then to Mars! Wow! Imagine what change in SP you will get with 0 (zero) volume....to Mars!
127
Discussion
Post by Pascalbioson Apr 27, 2021 9:25am

>>>>>>>>>>>>> PAS open at 0.085¢ <<<<<<<<<<<<<<<<<

V:PAS - PASCAL BIOSCIENCES INC - https://www.pascalbiosciences.com 09:23:30 EDT Live Quote  Sym-X Bid - Ask Last Chg  ...more  
86
Post by Pascalbioson Apr 27, 2021 8:35am

> Pascal Biosciences Announces Management Changes <

Pascal Biosciences Inc. (“Pascal” or the “Company”) (TSXV:PAS) (OTC:BIMUF), a biotechnology company that specializes in cancer, cannabinoids, and Covid-19 is announcing several management changes ...more  
100
Post by Pascalbioson Apr 27, 2021 8:33am

Pascal Biosciences Confirms Specific Cannabinoids Combat Cor

Pascal Biosciences Confirms Specific Cannabinoids Combat Coronavirus Pascal Biosciences Inc. (TSX.V:PAS) (OTC:BIMUF) (“Pascal” or the “Company”) today announced the Company has confirmed an earlier ...more  
95
Post by Pascalbioson Apr 26, 2021 10:29am

PASCAL BIOSCIENCES CONFIRMS SPECIFIC CANNABINOIDS COMBAT COR

Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the "Company") today announced the Company has confirmed an earlier report that certain cannabinoids block ...more  
96
Post by Pascalbioson Apr 26, 2021 10:26am

PASCAL BIOSCIENCES AND S?RSE TECHNOLOGY OPTIMIZE CANNABINOID

Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the "Company") and SRSE Technology Corporation ("SRSE") have validated and optimized a formula for oral ...more  
88
Post by Pascalbioson Apr 26, 2021 10:25am

PASCAL BIOSCIENCES TO PRESENT AT CANNABINOID DERIVED PHARMAC

Pascal Biosciences, Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:BIMUF), will present at the firstCannabinoid Derived Pharmaceuticals Industry Review Summit today. Dr ...more  
82
Post by Pascalbioson Apr 26, 2021 8:52am

> PAS-393 for Cancer <

Cannabinoid-based therapeutic for restoring immune recognition Advanced cancers typically become invisible to the immune system, thus allowing them to evade elimination. PAS-393 is a cannabinoid ...more  
95
Post by Pascalbioson Apr 26, 2021 8:51am

> PAS-403 for Glioblastoma <

Cannabinoid-based therapeutic for glioblastoma PAS-403 (previously known as ST-403) is a mitosis inhibitor that blocks cell division. The cannabinoid-based product is undergoing development for the ...more  
132
Post by Pascalbioson Apr 26, 2021 8:22am

> Cannabinoid therapeutic for treating COVID-19 <

The coronavirus pandemic has triggered a massive, worldwide effort to develop effective vaccines and treatments. With a previous focus on cancer, Pascal’s scientists directed their efforts to ...more  
123
Post by Pascalbioson Apr 25, 2021 8:09pm

> Cannabinoids in Medicine <

Cannabinoids can be categorized into three main groups: endocannabinoids, phytocannabinoids, and synthetic cannabinoids. Endocannabinoids are the hormone-like messengers of the mammalian ...more  
115
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities